Data / Form D filings / Theravie Pharma, Inc.
Theravie Pharma, Inc.: Form D filing
Theravie Pharma, Inc., a biotechnology company in San Diego, CA, filed a Form D with the SEC in 2026. The latest, on October 19, 2026, reports $750,000 sold of a $2.3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8525 GIBBS DRIVE SUITE 304, San Diego, CA, 92123
- Phone
- (858) 308-2977
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2160768
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 19 | New notice | $2,250,000 | $750,000 | $1,500,000 | 1 | Sep 29 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Samia Lina Helena Almoughrabie | Executive Officer, Director | |
| Richard Louis Gallo | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $22.9 million · Oct 21
- Adela, Inc. $12 million · Oct 19
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16
- Renue Life Sciences, Inc. $250,000 · Oct 14
- Tempest Therapeutics, Inc. $7.5 million · Oct 14
- Lionheart Health, Inc. $387,500 · Oct 7
Every Form D from the week of Oct 19 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Theravie Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.